Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
Perelman Center for Advanced Medicine, University of Pennsylvania. Our lab specializes in therapeutic gene editing, with a specific focus on using next-generation CRISPR tools for in vivo gene editing to
-
fully funded positions focus on experimental research in gene editing and gene therapy , addressing therapeutic applications for inherited retinal diseases, enzymatic deficiency disorders, lysosomal
-
editing techniques to investigate how super-enhancer dysregulation contributes to B-cell acute lymphoblastic leukaemia. The project applies sophisticated gene editing techniques such as CRISPR
-
Leibniz-Institute for Plant Genetics and Crop Plant Research | Neu-Seeland, Brandenburg | Germany | about 2 months ago
: Exploit the power of gene editing at the transcriptome scale to identify genes that regulate root system architecture and uptake mechanisms for efficient nitrogen capture. The project combines large-scale
-
generation sequencing (whole genome sequencing, exome sequencing, RNA-seq, ChIP-seq, Hi-C), array CGH, droplet digital PCR, and genome editing. Postdoctoral Associate will study the genetic bases of
-
to teach BIOL 6216 Applied Bioinformatics for the Cell and Gene Therapy Master’s Programs, depending on program needs and enrollment. This course introduces foundational bioinformatics concepts
-
. About Intellia Intellia Therapeutics is a Cambridge-based biotechnology company focused on developing clustered regularly interspaced short palindromic repeats (CRISPR)-based gene editing therapies to
-
regularly interspaced short palindromic repeats (CRISPR)-based gene editing therapies to transform lives of people with severe diseases. In fact, Intellia's co-founder Jennifer Doudna along with Emmanuelle
-
of embryonic neuronal development by combining genomics, gene editing, and bioinformatics. We offer an international, dynamic, and supportive research environment that fosters creativity and career
-
disease (VWM) and metachromatic leukodystrophy (MLD). You will investigate the efficacy and safety of AAV gene therapy in VWM and MLD mouse models. In addition, you will use genome-editing approaches